Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Insulin NovoRapid Better Than Actrapid for Treating Type 1 Diabetic Patients When Simultaneously, Daily Adjusting the Insulin Dose?

NCT00145353 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT00145353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00145353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Insulin NovoRapid Better Than Actrapid for Treating Type 1 Diabetic Patients When Simultaneously, Daily Adjusting the Insulin Dose?
Lead sponsor
Odense University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2004
Completion date
June 30, 2006
Enrollment
16
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus